Abstracts Archive - Page 278 of 1683 - ATC Abstracts

2021 American Transplant Congress
Bamlanivimab for Covid-19 in Kidney Transplant Patients
M. Y. Jan, S. El-Sayegh, M. S. Yaqub, D. P. Mishler, O. Adebiyi, M. D. Anderson, T. E. Taber, A. Sharfuddin
Nephrology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Treatment options for patients with COVID 19 have limited efficacy in reducing severity and duration of viral symptoms as well as progression to severe…
2021 American Transplant Congress
Panic in the Pandemic: A Medical Decision Analysis Examining When Kidney Transplant Programs Should Close
A. J. Vinson¹, B. Kiberd², K. Tennankore¹
¹Nova Scotia Health Authority Division of Nephrology, Departm, Halifax, NS, Canada, ²Dalhousie University, Halifax, NS, Canada
*Purpose: Pandemics greatly interfere with overall health care delivery as resources are diverted to combat the crisis. Kidney transplantation programs were closed temporarily during the…
2021 American Transplant Congress
Donor Derived Cell-Free DNA (dd-cfDNA) in Pancreas Transplant Recipients
S. Riad¹, H. Sarumi², R. Kandaswamy³
¹Medicine, University of Minnesota, Minneapolis, MN, ²Surgery, University of Minnesota Physicians, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Data on the role of DD-cfDNA after pancreas transplantation is lacking. Herein we report on our center experience with DD-cfDNA in 10 unique SPK…
2021 American Transplant Congress
COVID-19 Presentation and Severity Within One Year of Pancreas and Kidney Transplantation
H. Sarumi, J. Fisher, B. Johnson, T. Pruett
University of Minnesota, Minneapolis, MN
*Purpose: The current pandemic has created uncertainty of induction regimen impact upon severity of COVID-19 disease. Our experience with COVID-19 infection was reviewed to stratify…
2021 American Transplant Congress
SPK Transplantation in HIV-positive Recipients
H. Resweber, k. nguyen, H. Curtis, J. Panichella, A. DI Carlo, S. Karhadkar
Temple University School of Medicine, Philadelphia, PA
*Purpose: With the advent of anti-retroviral therapy in the treatment of HIV, mortality in HIV-infected individuals has become less due to complications from viral infection…
2021 American Transplant Congress
Baseline Levels of Dd-cf Dna After Pancreas Transplantation: Using Dd-cfdna as an Indicator for Pancreas Rejection and Biopsy Avoidance
A. Yoo, I. Qian, A. Riedel, C. Cazac, A. Bartosic, J. S. Bromberg, J. Scalea
Department of Surgery, Division of Transplant, University of Maryland School of Medicine, Baltimore, MD
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) testing, which has been previously validated for monitoring kidney transplant (KTx) rejection, may provide an alternative to pancreas biopsy that…
2021 American Transplant Congress
Utility of Donor-Derived Cell Free DNA for Detecting ABMR in Patients With AT1R Antibodies
S. Kant¹, D. Kumar², I. Moinuddin², T. Alhamad³, M. Haris³, J. Gray⁴, B. Dale⁴, M. Bettinotti¹, D. C. Brennan¹
¹Johns Hopkins University School of Medicine, Baltimore, MD, ²VCU, Richmond, VA, ³Wash Univ, St. Louis, MO, ⁴CareDx, Brisbane, CA
*Purpose: The presence of angiotensin II type 1 receptor (AT1R) antibodies is associated with non-HLA active antibody mediated rejection (ABMR). The frequent co-existence of negative…
2021 American Transplant Congress
The Impact of Tacrolimus IPV and TTR on the Development of De Novo Donor-specific Antibodies in Kidney Transplant Recipients
D. Xu¹, K. Richards¹, K. Zheng¹, H. Patel², F. Cardarelli², J. A. Pena³, A. Aala²
¹Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, ²Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, ³Pathology, Beth Israel Deaconess Medical Center, Boston, MA
*Purpose: High intrapatient variability (IPV) and low time in therapeutic range (TTR) of tacrolimus (TAC) may increase the risk of developing de novo donor-specific antibodies…
2021 American Transplant Congress
Changes in Glomerular Filtration Rate (delta Egfr) within the First Year Predict Long-Term Outcomes of Renal Grafts
A. M. Thompson, M. Zenati, S. Hariharan, M. Molinari
Starzl Transplant Institute, UPMC, Pittsburgh, PA
*Purpose: The relationship between changes in eGFR (Delta eGFR) during the first year after renal transplantation (RT) and long-term graft survival are poorly understood. We…
2021 American Transplant Congress
I Would Do Whatever It Took”: Understanding the Motivation, Education and Experiences of Kidney Paired Donation Participants
R. Pines¹, Y. A. Iraheta², L. Ambriz², K. A. Dahmani², E. H. Wood², M. Cooper³, A. D. Waterman²
¹Santa Barbara Cottage Hospital, Santa Barbara, CA, ²UCLA David Geffen School of Medicine, Los Angeles, CA, ³Medstar Georgetown Transplant Institute, Washington, DC
*Purpose: To improve kidney paired donation (KPD) educational programs, we conducted semi-structured interviews to understand motivations of past recipients and donors to participate in KPD,…